Cardiology-trained physician with subspecialty training at Erasmus Medical Centre, seeking consultant-track opportunities in the UAE — clinical depth in advanced echocardiography and heart failure, with a distinctive edge in AI-driven cardiovascular innovation.
I trained through internal medicine into cardiology across some of the Netherlands' leading academic and teaching hospitals — Franciscus Gasthuis, Albert Schweitzer Hospital, and accredited subspecialty training at Erasmus Medical Centre, one of Europe's top-ranked university medical centres, where I completed extensive rotations in advanced echocardiography, heart failure and preventive cardiology.
Day to day, my clinical focus sits across advanced transthoracic and transoesophageal echocardiography, guideline-directed heart failure management, and preventive cardiology and lipidology — underpinned by EACVI, ESC/HFA and ESC/EAS subspecialty certification completed within the past year.
Alongside clinical practice, I hold formal AI-in-healthcare training from Stanford University and Harvard Medical School, and I'm a peer-reviewed published researcher. I'm now directing that combination — bedside cardiology experience plus a genuine grounding in applied AI — toward how wearable and AI-driven tools can support earlier, more personalised cardiovascular care, through Healthineering.
Progressive training across internal medicine and cardiology in leading Dutch academic and teaching hospitals.
Cardiology Registrar, Accredited Subspecialty Training
Erasmus Medical Centre, Rotterdam
Advanced TTE/TOE echocardiography, guideline-directed heart failure management, preventive cardiology and lipidology at one of Europe's leading academic medical centres — the clinical foundation for current work in AI-driven cardiovascular diagnostics.
Cardiology Registrar
Albert Schweitzer Hospital, Dordrecht
Full inpatient and outpatient cardiology caseload, echocardiographic assessment and acute cardiac decision-making.
Internal Medicine Registrar
Franciscus Gasthuis, Rotterdam
Broad, multi-morbid inpatient care through a demanding COVID-era hospital environment — the diagnostic foundation for current cardiology practice.
Investigator, Pharmacy & Cardiology Department
Erasmus Medical Centre, Rotterdam
Peer-reviewed research on drug-induced QTc prolongation; contributor to the Halt & Reverse atrial fibrillation and aortic stenosis mapping trial.
Co-Founder & Director of Research and Technology, Healthineering
Health & Human Sciences Engineering
Health-promotion and digital health-literacy initiatives from 2011; now redirected toward AI-driven cardiology diagnostics and wearable-integrated risk modelling.
An observational study quantifying how often the combination of ciprofloxacin and fluconazole — commonly used as infection prophylaxis in haematology patients — prolongs the QTc interval, and which patient factors carry the greatest risk. The findings fed directly into safer antimicrobial-prescribing practice around cardiac risk.
"The next decade of cardiology will be defined less by new hardware and more by how intelligently we use the signal we already collect — from the echo probe to the wrist."
Wearable ECG, PPG and activity data are rich enough to support earlier, more individualised risk detection than most current workflows use. The opportunity is extracting clinically meaningful signal from continuous, everyday data — not just episodic snapshots.
Combining wearable-derived signals with clinical history and imaging findings to move cardiology from episodic, reactive evaluation toward personalised, continuous risk profiling — surfacing deterioration earlier, before symptoms present.
Decision-support tools should sit naturally alongside the clinician, not replace clinical judgement. My interest is in translating promising models into practice that physicians actually trust and patients actually benefit from.